Nazara Tech Infuses $77M (~₹734 Cr) as Second Tranche for Target Companies Acquisition
Nazara UK infused USD 77 million (~₹734.35 Crores) into its equity. This forms the second tranche payment of USD 77 million (~₹734.35 Crores) towards the acquisition of Target Companies, Bluetile Games and Bestplay Systems. The total consideration for the acquisition is USD 303.02 million (~₹2990 Crores).
The transaction involves a substantial amount of capital infusion and payment towards a significant acquisition, which is expected to have a material impact on the company's financial performance and strategic positioning.
The company has made a significant cash payment as part of an acquisition, which is a positive development indicating progress in its growth strategy.
Nazara Technologies Limited announced on October 30, 2026, that its wholly-owned subsidiary, Nazara UK, has received an infusion of USD 77.00 million (approximately ₹734.35 Crores) through the subscription of its equity shares. This infusion is part of the Amended and Restated Share Purchase Agreement (Amended SPA) for the acquisition of Bluetile Games, S.L. and Bestplay Systems, S.L. (collectively, the Target Companies).
Further to this, on October 30, 2026, Nazara UK paid USD 77.00 million (approximately ₹734.35 Crores) in cash as the second tranche of the total consideration of USD 303.02 million (approximately ₹2990 Crores) payable to the sellers for the acquisition. The remaining balance consideration will be discharged as per the terms outlined in the Amended SPA, with further updates to be provided in due course.
As a result of these transactions, the Target Companies will continue to be wholly-owned subsidiaries of Nazara UK and, by extension, step-down subsidiaries of Nazara Technologies Limited.
What to do with a filing like this
Nazara Technologies Limited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Nazara Technologies Limited. Read the original for the full detail.